Research Article

Modulation of the Ribonucleotide Reductase-Antimetabolite Drug Interaction in Cancer Cell Lines

Table 1

𝐼 𝐶 5 0 ratios of clones with high and low RRM1 expression of three cell lines for different cytotoxic agents.

H23MCF7HCT8
ControlRRM1 upRRM1 downControlRRM1 upRRM1 downControlRRM1 upRRM1 down
IC50IC50 RatioIC50 RatioIC50IC50 RatioIC50 RatioIC50IC50 RatioIC50 Ratio
𝜇 M Mean + / SEMean + / SE 𝜇 M Mean + / SEMean + / SE 𝜇 M Mean + / SEMean + / SE

Antimetabolites
 Gemcitabine0.010 1 . 8 0 0.22 0 . 4 4 0.060.008 1 0 . 1 1 0.92 0 . 4 7 0.120.013 1 . 8 0 0.16 0 . 4 9 0.08
 Hydroxyurea686.4000.870.011.180.050.9601.110.04 0 . 5 0 0.051547.9001.200.10 0 . 5 7 0.02
 Methotrexate0.025 2 . 3 0 0.210.870.260.0221.010.071.140.060.0261.030.121.030.17
 Pemetrexed0.105 2 . 4 9 0.250.800.020.036 0 . 6 2 0.031.200.090.109 0 . 4 9 0.07 2 . 1 0 0.38
 5-Fluorouracil0.911 2 . 0 9 0.97 0 . 2 3 0.053.183 2 . 7 2 1.27 0 . 5 9 0.2639.223 5 . 5 6 0.50 0 . 4 4
Platinum Compounds
 Cisplatin2.692 1 . 5 4 0.06 0 . 7 5 0.0225.1611.130.020.800.045.653 0 . 7 9 0.041.040.11
 Carboplatin66.328 1 . 3 1 0.61 0 . 5 9 0.16120.0000.970.081.150.0921.558no datano data
Mitosis Inhibitors
 Docetaxel0.0031.210.440.900.170.0010.890.120.790.120.0130.940.161.180.04
 Vinorelbine0.0340.960.161.000.210.0101.020.100.980.140.0720.980.101.140.14
Topoisomerase Inhibitors
 Etoposide0.2271.150.061.140.060.2910.890.101.060.110.1831.180.141.030.17

IC50 values for the wild-type cell lines for each of the drugs tested are listed in the column labeled “Control”. The IC50 ratios for RRM1 up- and down-regulated clones for cell lines H23, MCF7, and HCT8 were calculated as described in the Material and Methods section. Values greater than 1 indicated that higher drug concentrations are required to reach the IC50; that is, drug resistance. Values smaller than 1 indicated that the lower drug concentrations are required to reach the IC50; that is, drug sensitivity. Indicates values considered to be significantly changed.